Urea C 13

CHEMBL2096648 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
61.0 g/mol
LogP
-1.4
Phase
4

Urea C-13 is a stable isotope-labeled form of urea containing carbon-13, used primarily as a diagnostic agent in the 13C-urea breath test to detect active Helicobacter pylori infection in the gastrointestinal tract. After oral ingestion, H. pylori urease cleaves 13C-urea to produce 13CO2, which is detected in exhaled breath, providing a non-invasive, radiation-free diagnostic test. It is also used in metabolic research studies investigating urea cycle function and protein metabolism.

الوزن الجزيئي

61,0480 g/mol

LogP

-1,40

TPSA

69,10 Ų

قاعدة ليبينسكي للخمسة

ناجح

المجالات العلاجية

آلية العمل

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

الآلية

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

N[13C](N)=O

InChI

InChI=1S/CH4N2O/c2-1(3)4/h(H4,2,3,4)/i1+1

Molecular Formula

CH4N2O

HBD / HBA

2 / 1

الروابط القابلة للدوران

0

الذرات الثقيلة

4

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

Urea C-13 is a stable isotope-labeled form of urea containing carbon-13, used primarily as a diagnostic agent in the 13C-urea breath test to detect active Helicobacter pylori infection in the gastrointestinal tract. After oral ingestion, H. pylori urease cleaves 13C-urea to produce 13CO2, which is detected in exhaled breath, providing a non-invasive, radiation-free diagnostic test. It is also used in metabolic research studies investigating urea cycle function and protein metabolism.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Urea C 13 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2096648. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 636363. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.